Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,057 Cr
up ₹95.5 Cr vs May 2025
- Stocks held
- 29
- down 1 vs May 2025
- Top 10 weight
- 61.8%
- of the portfolio in its ten largest
- Cash & debt
- 1.1%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 9
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In June 2025 it disclosed 29 stocks worth ₹3,057 Cr, up ₹95.5 Cr from May 2025. Its largest positions were Cipla Limited (8.8%), Sun Pharmaceutical Industries Limited (8.4%), Suven Pharmaceuticals Limited (7.9%); the ten largest together made up 61.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.0% of its equity. Cash and debt stood at 1.1%. Compared with May 2025 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
87%
Top-10 weight is higher than 87% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
15%
Holds more cash than 15% of peers
Holdings in June 2025
Download CSVEvery line the fund disclosed, with the change against May 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.82%
- Δ weight
- down 0.04 pts
- Value
- ₹270 Cr
- Δ value
- up ₹7.2 Cr
- Status
- Added
- Weight
- 8.42%
- Δ weight
- down 0.28 pts
- Value
- ₹257 Cr
- Δ value
- down ₹29 L
- Status
- Held
- Weight
- 7.88%
- Δ weight
- down 0.93 pts
- Value
- ₹241 Cr
- Δ value
- down ₹19.9 Cr
- Status
- Trimmed
- Weight
- 7.71%
- Δ weight
- down 0.45 pts
- Value
- ₹236 Cr
- Δ value
- down ₹5.9 Cr
- Status
- Trimmed
- Weight
- 5.52%
- Δ weight
- up 0.58 pts
- Value
- ₹169 Cr
- Δ value
- up ₹22.6 Cr
- Status
- Added
- Weight
- 5.26%
- Δ weight
- up 0.69 pts
- Value
- ₹161 Cr
- Δ value
- up ₹25.6 Cr
- Status
- Added
- Weight
- 4.85%
- Δ weight
- down 0.06 pts
- Value
- ₹148 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 4.61%
- Δ weight
- up 0.09 pts
- Value
- ₹141 Cr
- Δ value
- up ₹7 Cr
- Status
- Added
- Weight
- 4.44%
- Δ weight
- down 0.15 pts
- Value
- ₹136 Cr
- Δ value
- down ₹26 L
- Status
- Held
- Weight
- 4.31%
- Δ weight
- up 0.23 pts
- Value
- ₹132 Cr
- Δ value
- up ₹10.8 Cr
- Status
- Added
- Weight
- 4.28%
- Δ weight
- up 0.47 pts
- Value
- ₹131 Cr
- Δ value
- up ₹18.2 Cr
- Status
- Added
- Weight
- 3.73%
- Δ weight
- down 0.08 pts
- Value
- ₹114 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 3.36%
- Δ weight
- up 0.62 pts
- Value
- ₹103 Cr
- Δ value
- up ₹21.6 Cr
- Status
- Added
- Weight
- 3.16%
- Δ weight
- down 0.29 pts
- Value
- ₹96.5 Cr
- Δ value
- down ₹5.6 Cr
- Status
- Trimmed
- Weight
- 3.06%
- Δ weight
- down 0.02 pts
- Value
- ₹93.7 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 3.02%
- Δ weight
- down 0.01 pts
- Value
- ₹92.2 Cr
- Δ value
- up ₹2.7 Cr
- Status
- Added
- Weight
- 2.95%
- Δ weight
- up 0.06 pts
- Value
- ₹90.1 Cr
- Δ value
- up ₹4.5 Cr
- Status
- Added
- Weight
- 2.85%
- Δ weight
- down 0.14 pts
- Value
- ₹87.2 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 1.64%
- Δ weight
- down 0.08 pts
- Value
- ₹50.2 Cr
- Δ value
- down ₹76 L
- Status
- Trimmed
- Weight
- 1.61%
- Δ weight
- up 0.08 pts
- Value
- ₹49.3 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 1.45%
- Δ weight
- down 0.09 pts
- Value
- ₹44.3 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 1.28%
- Δ weight
- down <0.01 pts
- Value
- ₹39 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 1.20%
- Δ weight
- down 0.02 pts
- Value
- ₹36.8 Cr
- Δ value
- up ₹68 L
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.10%
- Δ weight
- up 0.68 pts
- Value
- ₹33.6 Cr
- Δ value
- up ₹21.3 Cr
- Status
- Added
- Weight
- 0.74%
- Δ weight
- down 0.07 pts
- Value
- ₹22.7 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Weight
- 0.60%
- Δ weight
- down 0.04 pts
- Value
- ₹18.4 Cr
- Δ value
- down ₹60 L
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.58%
- Δ weight
- up 0.03 pts
- Value
- ₹17.7 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 0.57%
- Δ weight
- down 0.06 pts
- Value
- ₹17.4 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 0.46%
- Δ weight
- down <0.01 pts
- Value
- ₹14.1 Cr
- Δ value
- up ₹31 L
- Status
- Added
- Weight
- 0.40%
- Δ weight
- up 0.04 pts
- Value
- ₹12.2 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 0.13%
- Δ weight
- up 0.03 pts
- Value
- ₹3.8 Cr
- Δ value
- up ₹97 L
- Status
- Added
What changed, May 2025 to Jun 2025
New New positions (0)
None.
Exited Exited (1)
- Narayana Hrudayalaya Limitedwas 0.8% · ₹24.1 Cr
Added Biggest additions
- Laurus Labs Limitedup ₹25.6 Cr (+0.69% pts)
- Gland Pharma Limitedup ₹22.6 Cr (+0.58% pts)
- Indoco Remedies Limitedup ₹21.6 Cr (+0.62% pts)
- Illumina Incup ₹18.2 Cr (+0.47% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2025, the weight rose most in Pharmaceuticals (+0.6 pts), and fell most in Healthcare Services (−0.5 pts) and Healthcare Equipment & Supplies (−0.2 pts).
- Pharmaceuticals5.7% → 6.3%+0.6 pts
- Healthcare Services17.2% → 16.7%−0.5 pts
- Healthcare Equipment & Supplies8.0% → 7.8%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2022 | Jun 2024 | Dec 2024 | Mar 2025 | May 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 57.1% | 68.8% | 66.4% | 66.4% | 66.9% | 67.0% |
| Healthcare Services | 26.0% | 14.8% | 17.3% | 17.2% | 17.2% | 16.7% |
| Healthcare Equipment & Supplies | 5.4% | 8.4% | 8.5% | 8.7% | 8.0% | 7.8% |
| Pharmaceuticals | 7.6% | 5.6% | 5.9% | 5.7% | 5.7% | 6.3% |
| Insurance | 2.5% | 1.8% | 1.3% | 1.5% | 1.5% | 1.6% |
| Retailing | 1.3% | 0.5% | 0.5% | 0.5% | 0.6% | 0.6% |
Allocation in Jun 2025change vs May 2025
- Pharmaceuticals & Biotechnology (14)67.0%▲ 0.1 pts
- Healthcare Services (7)16.7%▼ 0.5 pts
- Healthcare Equipment & Supplies (3)7.8%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jun 2025
1.1%
▲ 0.7 pts vs May 2025
- Cash alone
- 1.1%
- cash and net receivables
- A year earlier
- 1.9%
- Jun 2024 · now ▼ 0.8 pts
- Last 12 months
- 0.1% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.